Study: 80% of soldiers improve with experimental PTSD therapy
Early results from a clinical trial at HaEmek Medical Center suggest MDMA-assisted psychotherapy could help combat veterans recover from PTSD, with most participants no longer meeting the criteria for the disorder
Assessment
A clinical trial at HaEmek Medical Center reports that 80% of combat veterans with PTSD improved after MDMA-assisted psychotherapy, with most no longer meeting diagnostic criteria. If replicated, this could shift treatment options for a condition that has proven resistant to conventional therapies. The next step will be larger trials and regulatory review.